Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: A new target to treat portal hypertension?-Reference-Cited by-同舟云学术

Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: A new target to treat portal hypertension?

Published:2005-11 Issue:5 Volume:43 Page:791-798
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Sansoè Giovanni,Aragno Manuela,Mastrocola Raffaella,Restivo Francesca,Mengozzi Giulio,Smedile Antonina,Rosina Floriano,Danni Oliviero,Parola Maurizio,Rizzetto Mario

Publisher

Elsevier BV

Subject

Hepatology

Reference50 articles.

1. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough;Wiest;Hepatology,2002

2. Natriuretic peptides;Levin;N Engl J Med,1998

3. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis;Brenard;J Hepatol,1992

4. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis;Komeichi;J Hepatol,1995

5. Hemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis;Moreau;Liver,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats;Journal of the Chinese Medical Association;2023-07-18

2. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System;Journal of the Renin-Angiotensin-Aldosterone System;2023-07-12

3. The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation;Scientific Reports;2023-01-18

4. The Classical and Nonclassical Renin-Angiotensin-Aldosterone System in Liver Cirrhosis;The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases;2023

5. COVID‐19 and Liver Cirrhosis: Focus on the Nonclassical Renin‐Angiotensin System and Implications for Therapy;Hepatology;2021-07-26